Literature DB >> 9434746

Turnover of recombinant human hemoglobin in Escherichia coli occurs rapidly for insoluble and slowly for soluble globin.

M J Weickert1, S R Curry.   

Abstract

Co-expression of di-alpha-globin and beta-globin in Escherichia coli in the presence of exogenous heme yielded high levels of soluble, functional recombinant human hemoglobin (rHb1.1) and, under certain conditions, large amounts of insoluble globin protein. Insoluble rHb1.1 accumulated in large, amorphous inclusion bodies visible by electron microscopy. The half-life of soluble rHb1.1 in E. coli, measured by pulse-chase experiments, was at least 11 h for each globin subunit. The in vivo half-life for insoluble globin was about fivefold shorter than that for soluble rHb1.1. We expressed significant amounts of each subunit, di-alpha-globin and beta-globin, independently with exogenous heme. The half-life of the soluble subunits alone was approximately 1 and 4 h, respectively, shorter than when they were expressed together as rHb1.1. Individually, the insoluble di-alpha-globin subunit had a half-life of just under 1 h when exogenous heme was added, but under 20 min when exogenous heme was not provided. The greater persistence of insoluble subunits in the presence of heme indicated that heme may stabilize the insoluble globin protein. The soluble rHb1.1 persistence in the E. coli cytoplasm during long periods of stationary phase growth indicated that once assembled, rHb1.1 is extremely resistant to proteolysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434746     DOI: 10.1006/abbi.1997.0410

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  High-fidelity translation of recombinant human hemoglobin in Escherichia coli.

Authors:  M J Weickert; I Apostol
Journal:  Appl Environ Microbiol       Date:  1998-05       Impact factor: 4.792

2.  Development of a method to produce hemoglobin in a bioreactor culture of Escherichia coli BL21(DE3) transformed with a plasmid containing Plesiomonas shigelloides heme transport genes and modified human hemoglobin genes.

Authors:  B J Z Smith; P Gutierrez; E Guerrero; C J Brewer; D P Henderson
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

3.  Enhancement of recombinant hemoglobin production in Escherichia coli BL21(DE3) containing the Plesiomonas shigelloides heme transport system.

Authors:  D M Villarreal; C L Phillips; A M Kelley; S Villarreal; A Villaloboz; P Hernandez; J S Olson; D P Henderson
Journal:  Appl Environ Microbiol       Date:  2008-08-01       Impact factor: 4.792

Review 4.  The role of alpha-hemoglobin stabilizing protein in redox chemistry, denaturation, and hemoglobin assembly.

Authors:  Todd L Mollan; Xiang Yu; Mitchell J Weiss; John S Olson
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

5.  A mutation that improves soluble recombinant hemoglobin accumulation in Escherichia coli in heme excess.

Authors:  M J Weickert; M Pagratis; C B Glascock; R Blackmore
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

6.  Monodisperse 130 kDa and 260 kDa Recombinant Human Hemoglobin Polymers as Scaffolds for Protein Engineering of Hemoglobin-Based Oxygen Carriers.

Authors:  David A Marquardt; Michael P Doyle; Jeffrey S Davidson; Janet K Epp; Jacqueline F Aitken; Douglas D Lemon; Spencer J Anthony-Cahill
Journal:  J Funct Biomater       Date:  2012-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.